國際醫學期刊論文發表 

  1. Chia-Yau ChangCherng-Lih Perng、Shin-Nan Cheng、Shu-Hsia Hu、Tzu-Ying Wu、Shyr-Yi Lin、Yeu-Chin Chen*. Deep Intronic Variant c.5999-277GA of F8 Gene May Be a Hot-Spot Mutation for Mild Hemophilia A Patients Without Mutation in Exonic DNA.  Eur J Haematol 2019;103(1):47-55. [SCI, IF: 2.595, Ranking 36/71=50.7%]
  2. Chia-Yau Chang, Yeu-Chin Chen, Chen-Hua Tsai, Jia-Ruey Tsai, Yen-Lin Liu, Shu-Hsia Hu. The Real-World Experience of rFVIII-Fc Used in Hemophilia A Patients in Taiwan: Prophylaxis Rates, Pharmacokinetics and Clinical Correlates, and the Effects on Joint Health. Blood 2019; 134(Suppl. 1): 2406. [SCI, IF: 16.562, Ranking 1/73=1.4%] 
  3. Chia-Yau ChangTsung-Ying Li、Shin-Nan Cheng、Ru-Yu Pan、Chao-Neng Cheng、Hung-Jung Wang、Shu-Hsia Hu、Yeu-Chin Chen*. Obesity and Overweight in Patients with Hemophilia:Prevalence by Age, Clinical Correlates, and Impact on Joint Bleeding. J Chin Med Assoc 2019; 82: 289-294. [SCI, IF: 1.66, Ranking 72/155=46.5%]
  4. Ting-Chih Lin, Shu-Huey Chen, Chung-Che Wu, Chia-Yau Chang* (corresponding author). Successful Bleeding Control of Refractory Hemothorax in Two Severe-Type Hemophilia A Patients with High-Titer Inhibitors. Pediatr Neonatol 2020;61(3):361-363. [SCI, IF: 1.497, Ranking 73/124=58.9%]
  5. Chia-Yau Chang、Chen-Hua Tsai、Jia-Ruey Tsai、Pei-Yi Lai、Yen-Lin Liu、Shu-Hsia Hu、Yeu-Chin Chen. The Real-World Experience of Product-Switching, Pharmacokinetics, and Adherence of rFVIII-Fc in Patients with Hemophilia A:The Preliminary Report in Taiwan. RPTH 2019;3(Suppl. 1):297. (PB0289)
  6. SS Chiou, CY Lin, JD. Wang, TF Weng, Chia-Yau Chang, CT Peng, MC Shen, Taiwan Society of Thrombosis and Hemostasis Study Group. The Outcome of Intermediate-dose Prophylaxis and On-demand Episodic Treatment for Severe Hemophilia A Patients in Taiwan - A Longitudinal Study. RPTH 2019;3(Suppl. 1):. (PB1417)
  7. Jia-Ruey Tsai, Chun-Yu Lin, Mei-Mei Cheng, Chia-Yau Chang* (corresponding author). Successful Treatment of Refractory Pancreatic Hemorrhage and Pseudoaneurysm Related to Chronic Pancreatitis in a Patient with Severe-Type Hemophilia A. KJMS 2019;35(7):448-449. [SCI, IF: 1.288, Ranking 110/133=82.7%]
  8. Chia-Yau ChangShu-Hsia HuShyr-Yi LinYeu-Chin Chen*. Successful Carrier Identification by Messenger RNA Analysis for One Hemophilia A Family Without Found DNA Mutations. Haemophilia 2018;24(Suppl.5):193. T-P-001(351) [SCI, IF: 3.569, Ranking 22/70=31.4%]
  9. Chia-Yau ChangChing-Yeh LinShyh-Shin ChiouTe-Fu WengJiaan-Der WangJyh-Pyng GauShu-Huey ChenYeu-Chin ChenChing-Tien Peng*Ming-Ching Shen*. Joint Outcomes of the Elbow, Knee and Ankles Evaluated by Hemophilia Joint Health Score in Patients with Hemophilia : Trends by Age and Clinical Predictors. Haemophilia 2018;24(Suppl.5):72-73. T-P-050(547) [SCI, IF: 3.569, Ranking 22/70=31.4%]
  10. Chia-Yau Chang、Shin-Nan Cheng、Shu-Hsia Hu、Tzu-Ying Wu、Shyr-Yi Lin、Yeu-Chin Chen*. 90-bp Insertion of Deep Intron Between E18 and E19 (E18ins90bpE19) May Be a Hot-Spot Mutation for Mild Hemophilia A Patients Without Found DNA Mutation. RPTH 2017; 1(Suppl.1):168-169. (OC50.4)
  11. Chia-Yau Chang、Tsung-Ying Li、Shin-Nan Cheng、Ru-Yu Pan、Hung-Jung Wang、Shu-Hsia Hu、Yeu-Chin Chen*. Obesity in Patients With Hemophilia:Prevalence by Age, Clinical Correlates and Impact on Joint Bleeding. RPTH 2017; 1(Suppl.1): 660. (PB 215)
  12. Chia-Yau Chang、Tsung-Ying Li、Shin-Nan Cheng、Ru-Yu Pan、Hung-Jung Wang、Shyr-Yi Lin、Yeu-Chin Chen*. Prevalence and Severity by Age and Other Clinical Correlates of Haemophilic Arthropathy of the Elbow, Knee, and Ankle among Taiwanese Patients With Haemophilia. Haemophilia 2017;23:284-291. [SCI, IF: 3.569, Ranking 22/70=31.4%]
  13. Chia-Yau Chang、Shyr-Yi Lin、Jia-Ruey Tsai、Chen-Hua Tsai、Yeu-Chin Chen. Successful Multivessel Percutaneous Coronary Intervention for Acute Coronary Syndrome in a HIV-positive Severe Hemophiliac. Haemophilia 2016; 22: e481-e484. [SCI, IF: 3.569, Ranking 22/70=31.4%] 
  14. Yeu-Chin Chen、Shin-Nan Cheng、Chia-Yau Chang、Shu-Hsia Hu. Messenger RNA analysis and multiplex ligation probe amplification for hemophilia A patients without found mutation or suspected exon(s) deletion in genomic DNA. Haemophilia 2016; 22(Suppl. 4): 33-34. 
  15. Lo PH, Huang YF, Chang CC, Yeh CC, Chia-Yau Chang, Cherng YG, Chen TL, Liao CC. Risk and Mortality of Gastrointestinal Hemorrhage in Patients with Thrombocytopenia:Two Nationwide Retrospective Cohort Studies. Eur J Intern Med 2016;27:86-90. [SCI, IF: 2.891, Ranking: 26/154= <17%]
  16. Ting-Lin Yen, Ming-Ping Wu, Chi-Li Chung, Wen-Bin Yang, Thanasekaran Jayakumar, Pitchairaj Geraldin, Chih-Ming Chou, Chia-Yau Chang, Wan-Jung Lu, Joen-Rong Sheu*. Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolism. J Biomed Sci 2016;23:26. [SCI, IF: 2.763, Ranking:50/123=40.7%]
  17. Lung-Te Wu, Hsien-Tsung Lu, Chih-Haw Chen, Alexander Ko, Chian-Her Lee*. Arthroscopic synovectomy considerably reduces bleeding frequency and improves joint function in hemophilic patients with chronic synovitis. Formosan J Surg 2016:49; 49-55.
  18. Chia-Yau Chang, Chun-Yao Huang, Tsai CH, Shen MC, Chen YC, Tsai JR, Yeh GC, Liu YL. Successful Multi-vessel Percutaneous Coronary Intervention for Acute Coronary Syndrome in a Severe Taiwanese Hemophiliac with HIV Infection under HARRT:The First Reported Case in Chinese Population. Journal of Thrombosis and Haemostasis 2015; 13(Suppl.2):589. [SCI, IF: 6.081, Ranking 7/67 < 10.5%]
  19. Chia-Yau Chang, Tsung-Ying Li, Shin-Nan Cheng, Ru-Yu Pan, Hung-Jung Wang, Shi-Yi Lin, Yeu-Chin Chen*. Prevalence, Severity and Correlation Factors of Hemophilic Arthropathy Among Taiwanese Hemophiliacs. Journal of Thrombosis and Haemostasis 2015; 13(Suppl.2):847-848. [SCI, IF: 6.081, Ranking 7/67 < 10.5%]
  20. Chia-Yau Chang , Shu-Huey Chen*, Yeh GC, Tsai CH, Tsai JR, Liu YL. Inhibitor Development as Switching Full-length rFVIII to B-domain deleted rFVIII in Previously Treated Patients with Hemophilia A:Taiwan’s Experience. Journal of Thrombosis and Haemostasis 2015; 13(Suppl.2):856-857. [SCI, IF: 6.081, Ranking 7/67 < 10.5%]
  21. Chia-Yau Chang, Yeh GC, Shi-Yi Lin, Ing-Jy Tseng, Tsai CH, Yuan-Wen Lee*. Trends in the Epidemiology, Diagnosed Age, and Mortality Rate of Hemophiliacs in Taiwan: A Population-Based Study, 1997-2009. Haemophilia 2014; 20(4): 535-40. doi: 10.1111/hae.12373. [SCI, IF: 3.17, Ranking 24/67=35.8%]
  22. Chia-Yau Chang, Shu-Hsia Hu, Shin-Nan Chien, Yeu-Chin Chen. Congenital coagulation Factor VII deficiency: A Clinical and Genetic Study of Taiwanese Patients. Haemophilia 2014; 20 (Suppl. 3): 106. [SCI, IF: 3.569, Ranking 22/70=31.4%]
  23. Mei-Mei Cheng, Chia-Yau Chang, Yuan-Wen Lee, Yeh GC, Liu YL, Tsai CH, Tsai JR. Co-morbidities and HIV Infection of Hemophiliacs in Taiwan: A Population-Based Study. Haemophilia 2014; 20 (Suppl. 3): 30-31. 
  24. Chia-Yau Chang, Chian-Her  Lee, Hsien-Tsung Lu, Jiunn-Horng Kang, Tsai CH, Yeh GC. Arthroscopic Synovectomy for Hemophilic Arthropathy of Hemophiliacs in Taiwan. Haemophilia 2014; 20 (Suppl. 3): 72.
  25. Chang CC,   Chang HC,  Wu CH,   Chia-Yau Chang,  Liao CC,  Chen TL*. Postoperative Adverse Outcomes in Surgical Patients with Immune Thrombocytopenia: A Population-based Study. British J Surg 2013; 100: 684-692. [SCI, IF: 4.6, Ranking 5/198 = 2.5%]
  26. Chia-Yau Chang, Yen GC, Lee YW*, Chen TL, Tseng IJ, Lin SY, Tsai CH, Tsai JR, Wang CH. Haemophilia in Taiwan: A Population-base Study on Epidemiology, Age at Diagnosis, Mortality, and 13-years Trend by National Health Insurance Research Database 1997-2009. Haemophilia 2012;18 (Suppl. 3): 44. [SCI, IF: 3.569, Ranking 22/70=31.4%]
  27. Chia-Yau Chang, Ying-Chieh Shih, Hung-Jung Wang, Ming-Shium Hsieh*. Popliteal Cyst Rupture in a Haemophiliac Presenting as Refractory Recurrent Hemorrhage of Right Lower Leg. Haemophilia 2011; 17: 320-322. [SCI, IF: 3.569, Ranking 22/70=31.4%]
  28. Chia-Yau Chang, Tsai CH, Tsai IR, Yen GC, Lin SY, Tseng IJ. Concurrence of type II von Willebrand Disease and Sever Hemophilia B in a Taiwanese: a Case Report and Review of Literature. Journal of Thrombosis and Haemostasis 2011; 9 (Suppl. 2): 450. [SCI, IF: 6.081, Ranking 7/67 < 10.5%]
  29. Chia-Yau Chang, Tsai CH, Tsai IR, Yen GC, Lin SY, Tseng IJ. Concurrence of Classic Type Ehlers-Danlos Syndrome and Moderate Hemophilia A in a Taiwanese: a Case Report. Journal of Thrombosis and Haemostasis 2011; 9 (Suppl. 2):475. [SCI, IF: 6.081, Ranking 7/67 < 10.5%]
  30. Chia-Yau Chang, Tsai CH, Tsai IR, Yen GC, Lin SY, Tseng IJ. Successful Treatment of Hemothorax and Intracranial Hemorrhage in a Taiwanese Hemophiliac with Inhibitors by Avtivated Recombinant Factor VII and Positive Pressure Ventilation. Journal of Thrombosis and Haemostasis 2011;9 (Suppl. 2):228-229. [SCI, IF: 6.081, Ranking 7/67 < 10.5%]
  31. Chia-Yau Chang, Tseng IJ, M. HSIEH*, Y. SHIH. Bone Mineral Density Among Adults with Hemophilia: the Preliminary Report in Taiwan. Haemophilia 2010;16 (Suppl. 4): 22. [SCI, IF: 3.17, Ranking 24/67=35.8%]

 

國際醫學會議口頭研究發表:

1. [韓國,光州] Chia-Yau Chang、Shiue-Wei Lai、Jia-Ruey Tsai、Yen-Lin Liu、Chen-Hua Tsai、Chao-Neng Cheng、Shu-Hsia Hu、Yeu-Chin Chen*. 2021 11th (On-line) Congress of the Asian Pacific Society on Thrombosis and Haemostasis (APSTH), in Gwangju, Korea. Extended Half-Life rFVIII Used in Taiwanese Patients with Hemophilia A: rFVIII-Fc Half Life and Clinical Predictors. 2021,03,20. (FP-0101)

2. [日本,札幌] Chia-Yau Chang、Shyh-Shin Chiou、Pei-Chin Lin、Shu-Hsia Hu、Yeu-Chin Chen*.  2018 10th Congress of the Asian Pacific Society on Thrombosis and Haemostasis (APSTH), in Sapporo, Japan. Genotype Analysis of Hemophilia B Patients in Taiwan. 2018,06,29. (O1-02)

3. [德國,柏林Chia-Yau Chang、Shin-Nan Cheng、Shu-Hsia Hu、Tzu-Ying Wu、Shyr-Yi Lin、Yeu-Chin Chen*. 90-bp Insertion of Deep Intron Between E18 and E19 (E18ins90bpE19) May Be a Hot-Spot Mutation for Mild Hemophilia A Patients Without Found DNA Mutation. 2017 International Society of Thrombosis and Hemostasis (ISTH). 2017,07,11. (OC 50.4)

4. [台灣,台中] Chia-Yau Chang. 2017 East Asia Hemophilia Forum (EAHF), Workshop. Cardiovascular Comorbidities and Ischemic Heart Disease in Patients with Hemophilia: Prevalence, Risk Factors and Management. 2017,10,6. (WS-05)

5. [台灣,台中] Chia-Yau Chang、Cherng-Lih Perng、Shin-Nan Cheng、Shu-Hsia Hu、Tzu-Ying Wu、Shyr-Yi Lin、Yeu-Chin Chen*. 2017 East Asia Hemophilia Forum (EAHF). Deep Intronic Variant of c.5999-299G>A May Be a Hot-Spot Mutation for Mild Hemophilia A Patients Without Found DNA Mutation. 2017,10.7. (O1-03)

6. [台灣,台中] Chia-Yau Chang、Ching-Yeh Lin, Chiou SS, Weng TF, Wang JD, Gau JP, Chen SH, Chen YC, Ching-Tien Peng*, Ming-Ching Shen*. 2017 East Asia Hemophilia Forum (EAHF). Joint Outcomes Evaluated by Hemophilia Joint Health Score in Patients with Hemophilia (PWH):Clinical Correlates and Impact on Life of PWH by the Hemophilia Study Group of TSTH. 2017,10.8. (O3-05)

7. [台灣,台北] Chia-Yau Chang、Shu-Hsia Hu、Shin-Nan Cheng、Shyr-Yi Lin、Yeu-Chin Chen*. 2016 Asia Pacific Society of Thrombosis and Hemostasis (APSTH). Genotype Characteristics of von Willebrand Disease in Taiwan. 2016,10.7.(O1-1)

8. [日本,奈良] Chia-Yau ChangTsung-Ying Li, Shin-Nan Cheng, Ru-Yu Pan, Hung-Jung Wang, Shi-Yi  Lin,Yeu-Chin Chen*. 2015 East Asia Hemophilia Forum (EAHF). Prevalence and Severity by Age and Other Clinical Correlates of Haemophilic Arthropathy of the Elbow, Knee, and Ankle among Taiwanese Patients With Haemophilia.2015,11,14.(1-B1)

9. [日本,奈良] Chia-Yau ChangShu-Huey Chen*, Chen-Hua Tsai, Jia-ruey Tsai, Geng-Chang Yeh, Shi-Yi Lin, Yen-Lin Liu. 2015 East Asia Hemophilia Forum (EAHF). Inhibitor Development as Switching Full-length rFVIII to B-domain deleted rFVIII in Taiwanese Previously Treated Patients with Hemophilia A.2015,11,14.(1-D3)

10. [日本,奈良] Chia-Yau ChangMing-Ching Shen, Yeu-Chin Chen, Chen-Hua Tsai, Jia-Ruey Tsai, Yen-Lin Liu, Geng-Chang Yeh,Chun-Yao Huang*. 2015 East Asia Hemophilia Forum (EAHF). Successful Multi-vessel Percutaneous Coronary Intervention for Ischemia Heart Disease in a Severe-type Hemophiliac with HIV Infection under HARRT:The First Case of Taiwan. 2015,11,15.(2-C3)

11. [澳洲,墨爾本] Chia-Yau Chang,  Ta-Liang Chen,  Yuan-Wen  Lee, Ing-Jy Tseng,  Shi-Yi Lin.  2012 Congress of the Asian Pacific Society on Thrombosis and Haemostasis (APSTH). Epidemiology, Demographics, Age at Diagnosis, and Mortality of Taiwanese Hemophiliacs: a Nationwide Study by National Health Insurance Research Database. 2012,10,31.(O126)

 

國際醫學會議研究海報發表(節錄):

1. Chia-Yau Chang, Ching-Yeh Lin, Shyh-Shin Chiou, Te-Fu Weng, Jiaan-Der Wang, Jyh-Pyng Gau, Shu-Huey Chen, Yeu-Chin Chen, Ching-Tien Peng, Ming-Ching Shen*. The Hemophilia Study Group of Taiwan Society of Thrombosis and Hemostasis (TSTH). Joint Outcomes of Pettersson Score and Hemophilia Joint Health Score in Patients with Hemophilia in Taiwan. 2016 Asia Pacific Society of Thrombosis and Hemostasis (APSTH). 2016,10,7. (P07-23)

2. Chia-Yau Chang、Te-Fu Weng、Jiann-Shiuh Chen、Shu-Hsia Hu、Shin-Nan Cheng、Shyr-Yi Lin、Yeu-Chin Chen*. Clinical Features and Genotypes of 10 Taiwanese Patients with Type 3 von Willebrand Disease. 2016 Asia Pacific Society of Thrombosis and Hemostasis (APSTH). 2016,10,7. (P08-02)

3. Chia-Yau Chang、Jiann-Shiuh Chen、Shu-Hsia Hu、Shin-Nan Cheng、Shyr-Yi Lin、Yeu-Chin Chen*. Genotype Characteristics of von Willebrand Disease in Taiwan. 2016 Congress of World Federation of Hemophilia (WFH). 2016,7,26. (PO-T-190)

4. Chia-Yau Chang、Jiann-Shiuh Chen、Shu-Hsia Hu、Shin-Nan Cheng、Shyr-Yi Lin、Yeu-Chin Chen*. Clinical Features and Genotypes of 6 Taiwanese Patients with Type 3 von Willebrand Disease. 2016 Congress of World Federation of Hemophilia (WFH). 2016,7,26. (PO-T-199)

5. Chia-Yau Chang, Hsien-Tsung Lu, Jiunn-Horng Kang, Chian-Her Lee. 2014 8th Congress of the Asian Pacific Society on Thrombosis and Haemostasis (APSTH). Arthroscopic Synovectomy in Hemophilic Arthropathy of the Knee, Elbow and Ankle: Taiwan Experience. 2014,10,9~11. (No.22)

6. Chia-Yau Chang, Yuan-Wen Lee, Ing-Jy Tseng, Chen-Hua Tsai, Yen-Lin Liu, Geng-Chang Yeh. 2013 East Asia Hemophilia Forum (EAHF). Mortality Rates and Human Immunodeficiency Virus Infection of Hemophiliacs in Taiwan: A Population-Based Study, 1997-2009. 2013,9,7~8.(P4)

7. Hsien-Tsung Lu, Chia-Yau Chang, Chian-Her Lee, Jiunn-Horng Kang. 2013 East Asia Hemophilia Forum (EAHF). Arthroscopic Synovectomy in Hemophilic Arthropathy of the Knee, Elbow and Ankle in Taiwan. 2013,9,7~8.(P3)

8. Chia-Yau Chang,  Cheng Mei-Mei,  Ing-Jy Tseng.  2012 7th Congress of the Asian Pacific Society on Thrombosis and Haemostasis (APSTH).  Platelet Dysfunction Exacerbated Irreversibly by Acquired Autoimmune Hypothyroidism in a Taiwanese Female with Congenital Storage Pool Disease – a Clinical Observation. 2012,10,29. (P052)

9. Cheng Mei-Mei,  Chia-Yau Chang *,  Ing-Jy Tseng.  2012 7th Congress of the Asian Pacific Society on Thrombosis and Haemostasis (APSTH). Childhood Antiphospholipid Syndrome Mimicking Hemophilia with Severe Arthralgia and Isolated Prolonged aPTT in a Taiwanese Boy – a Rare Case Report. 2012,10,29. (P111)

 

國內醫學會議口頭發表(節錄):

1. 張家堯賴學緯、劉彥麟、蔡振華、蔡佳叡、鄭兆能、胡淑霞、顧容慈、陳宇欽*台灣血栓暨止血學會109年度第二次學術研討會. 發展rFVIII-Fc半衰期的預測模式用以A型血友病患者的個人化預防性治療 Developing Predictive Models of rFVIII-Fc Half Life for Personalized Prophylaxis in Patients with Hemophilia A. 2020-11-14.

2. 張家堯、蔡振華、蔡佳叡、劉彥麟、胡淑霞、陳宇欽*. 台灣血栓暨止血學會109年度學術研討會. 台灣A型血友病患者以rFVIII-Fc做治療的臨床經驗:劑量打法的調整, 年度化出血率, 年度凝血因子的用量與費用, 與關節健康的效益 Clinical experience of rFVIII-Fc used in Patients with Hemophilia A in Taiwan: Regimen adjustment, annual bleeding rates, annual factor costs, correlation factors of pharmacokinetics, and effects on joint health. 2020-08-16.

3. 張家堯、蔡振華、蔡佳叡、胡淑霞、陳宇欽*. 中華民國血液病學會暨中華民國血液及骨髓移植學會109年度聯合學術年會. 台灣嚴重型A型血友病患者以rFVIII-Fc來做規律性預防性治療:預防性治療比率, 劑量打法, 臨床因子, 與關節健康的益處 Regular Prophylaxis with rFVIII-Fc for Patients with Severe Hemophilia A: Prophylaxis Rates, Regimen, Clinical Correlates, and the Benefits for Joint Health. 2020-08-01 (No.3)

4.李雅琳、郭聿航、程美美、劉彥麟、張家堯*. 臺灣兒科醫學會第240屆學術演講會: 母乳哺育之兒童缺鐵的研究:臨床特徵、合併缺鋅或發展遲緩 的盛行率、以及母親缺鐵之影響 Iron Deficiency in Breast-Feeding Children:Clinical Features, Prevalence of Concurrent Zinc Deficiency or Developmental Delay, and the Effect of Maternal Iron Status. 2019-11-09 (No.7)

5. 張家堯、蔡佳叡、蔡振華、劉彥麟. 台灣血栓暨止血學會108年度第二次學術研討會. 沒有關節疼痛或是隱約的關節酸痛 代表沒有關節出血嗎? 5個血友病患的輕度無症狀/微量的關節出血. No Joint Pain or Subtle Joint Sore, No Joint Bleed? Subclinical / Micro- Joint Bleeding in Five Patients with Hemophilia. 2019-05-18.

6. 張家堯、蔡振華、蔡佳叡、陳宇欽*. 中華民國血液病學會暨中華民國血液及骨髓移植學會108年度聯合學術年會. 台灣A型血友病患者使用rFVIII-Fc的藥品轉換、藥物動力學、與關節健康效應之真實世界的經驗 The Real-World Experience of rFVIII-Fc Used in Hemophilia A Patients in Taiwan: Product-Switching, Pharmacokinetics, and the Effects on Joint Health. 2019-04-13 (No.23)

7. 張家堯、蔡佳叡、蔡振華、劉彥麟. 台灣血栓暨止血學會108年度第一次學術研討會. 規律的中等劑量第八因子預防性治療能夠逆轉血友病關節病變嗎? 一個A型血友病兒童MRI追蹤的系列報告 Can Regular Prophylaxis with Intermediate-dose FVIII Reverse the Progress of Hemophilic Arthropathy? A Series of MRI Findings in a Boy with Hemophilia A. 2019,01,12 (No.2)

8. 張家堯、蔡振華、蔡佳叡、劉彥麟. 台灣血栓暨止血學會108年度第一次學術研討會. A型血友病患者使用rFVIII-Fc的藥品轉換與藥物動力學之真實世界的經驗:單一機構的初步報告 The Real-World Experience of Product-Switching and Pharmacokinetics of rFVIII-Fc in Hemophilia A Patients:The Preliminary Report in a Single Institute. 2019,01,12 (No.3)

9. 張家堯、胡淑霞、吳姿縈陳宇欽*. 中華民國血液病學會107年第二次聯合學術研討會:遺傳性第十一因子缺乏症之臨床表徵與基因研究: 四個案例報告 Clinical Phenotypes and Genetic Study of Inherited Factor XI Deficiency: Four Cases Report. 2018,11,03.(No.3)

10. 張家堯. 台灣血栓暨止血學會107年度第三次學術研討會. 專題演講:新型長效因子與非因子之血友病治療的最新發展:聚焦於FVIII-Fc-VWF與AT SiRNA (Novel Long-Acting Factor and Non-Factor Therapies for Hemophilia : Focusing on FVIII-Fc-VWF - Exten-A BIVV001 and AT SiRNA - Fitusiran). 2018,09,01.

11. 張家堯、邱世欣、林佩瑾、胡淑霞、陳宇欽*. 台灣血栓暨止血學會107年度第二次學術研討會. 台灣B型血友病患之基因型分析 Genotype Analysis of Hemophilia B Patients in Taiwan. 2018,06,02.

12. 張家堯、蔡佳叡、劉彥麟、王鴻蓉、胡淑霞、陳宇欽*. 台灣血栓暨止血學會107年度第一次學術研討會:與值大夜班相關之反覆排卵期疼痛與黃體破裂造成的大量腹腔出血之嚴重第一型類血友病女性 Midnight shift-related recurrent midcycle pain and ruptured corpus luteum bleeding during ovulation resulting in massive hemoperitoneum in a female with severe type 1 von Willebrand disease. 2018,01,13.

13. 蔡佳叡、林俊宇、蔡振華、劉彥麟、張家堯*. 台灣血栓暨止血學會107年度第一次學術研討會:成功治療一名帶有慢性胰臟炎與假性動脈瘤之重度A型血友病患的難治型胰臟反覆出血 Successful Treatment of Refractory Recurrent Pancreatic Hemorrhage in a Severe-type Hemophilia A Patient with Chronic Pancreatitis and Pseudoaneurysm. 2018,01,13.

14. 張家堯、錢新南、胡淑霞、吳姿宜、林時宜、陳宇欽*. 中華民國血液病學會暨中華民國血液及骨髓移植學會106年度聯合學術年會. 90-bp Insertion of Deep Intron Between E18 and E19 (E18ins90bpE19) May Be a Hot-spot Mutation for Mild Hemophilia A Patients Without Found DNA Mutation. 2017,4,15.(No.19)

15. 張家堯、胡淑霞、林時宜、陳宇欽*. 中華民國血液病學會、中華民國血液及骨髓移植學會第163次聯合學術研討會:成功辨識DNA無突變的血友病家族之女性帶因者 Successful Identification of Female Carriers of A Hemophilia A Family Without Found Mutations in DNA.. 2016-9-24.(No.10)

16. 張家堯. 台灣血栓暨止血學會105年度第二次學術研討會:類血友病2016年新知 Post-WFH review: An Update of Von Willebrand disease. 2016,9,10.

17. 張家堯、胡淑霞、錢新南、林時宜、陳宇欽*. 中華民國血液病學會、中華民國血液及骨髓移植學會105年度聯合學術年會:台灣類血友病患之基因型特徵 Genotype Characteristics of Von Willebrand Disease in Taiwan. 2016,4,16.

18. 張家堯、陳建旭、胡淑霞、錢新南、林時宜、陳宇欽*. 中華民國血液病學會、中華民國血液及骨髓移植學會105年度聯合學術年會:台灣六位第3型類血友病患之新奇基因突變與臨床表徵 Clinical Features and Novel Mutations of 6 Taiwanese Patients with Type 3 von Willebrand Disease. 2016,4,16.

19. 張家堯、胡淑霞、林時宜、陳宇欽*. 中華民國血液病學會、中華民國血液及骨髓移植學會第161次聯合學術研討會、台灣血栓暨止血學會104年度第三次學術研討會: 體顯性遺傳之新奇錯義突變之第一型類血友病父母所生第三型類血友病病患在近親結婚的一個台灣家庭 A Novel Missense Mutation of Type III VWD with Homozygous Dominant Inheritance in a Taiwanese Consanguineous Family. 2015,12,19.

20. 張家堯. 台灣血栓暨止血學會104年度第二次學術研討會:治療血友病之長效型凝血因子2015年新知 Post-ISTH review: Update Long-acting Clotting Factor Concentrates for Hemophilia. 2015,8,22.

21. 張家堯. 台灣血栓暨止血學會104年度第二次學術研討會:關於傳明酸用於外傷的治療2015年新知 Post-ISTH review: Update Tranexamic acid in Trauma. 2015,8,22.

22. 張家堯、黃群耀、蔡振華. 台灣血栓暨止血學104年度第一次學術研討會:成功以經皮冠狀動脈介入術治療發生急性冠心症的HIV陽性嚴重型血友病患者 - 台灣第一例案例報告 Successful Percutaneous Coronary Intervention for Ischemic Heart Disease in a Severe Hemophiliac with HIV infection under HARRT: The First Case Report in Taiwan. 2015,1,31.

23. 張家堯. 台灣血栓暨止血學會104年度第一次學術研討會:血友病患者的心血管疾病風險、以及處理其缺血性心臟病之歐洲ADVANCE研究群的指引建議 Cardiovascular Risks in Hemophiliacs and the Guidelines for Managing Ischemic Heart Disease in Hemophiliacs by ADVANCE working group.2015,1,31.

24. 張家堯. 台灣血栓暨止血學會103年度第二次學術研討會: 血友病患者的老年相關共病症2014年新知 Post-WFH review: Update of Aging-related Co-morbidities of Hemophiliacs. 2014,9,20.

25. 張家堯、王鴻蓉、曾櫻枝、蔡振華、蔡佳叡、呂憲宗、康峻宏、李建和*. 中華民國血液病學會、中華民國血液及骨髓移植學會第157次聯合學術研討會: 血友病關節病變的關節內視鏡滑液囊切除術治療的果效、安全性、與結果的預測因子 Effectiveness, Safety and Predictive Factors for Outcome of Arthroscopic Synovectomy for Hemophilic Arthropathies.2014,8,16.

26. 張家堯、李元文*、蔡振華、蔡佳叡. 台灣血栓暨止血學會103年度聯合年會: 台灣血友病患者的共病症: 一個全人口為基準的研究 Co-morbidities and HIV Infection of Hemophiliacs in Taiwan: A Population-Based Study. 2014,5,17.

27. 張家堯、呂憲宗、康峻宏、李建和*. 台灣血栓暨止血學會103年度聯合年會: 以關節內視鏡滑膜切除術治療台灣血友病患者的血友病關節病變  Arthroscopic Synovectomy for Hemophilic Arthropathy of Hemophiliacs in Taiwan. 2014,5,17.

28. 張家堯.台灣血栓暨止血學會102年度第二次學術研討會: 遺傳性血小板疾病2013年新知 Post-ISTH review: Inherited Platelet Disorders Update. 2013,8,24.

29. 張家堯.台灣血栓暨止血學會102年度聯合年會: 成功以免疫耐受性誘導治療法治療從全長度第八因子(FL-rFVIII)轉換為以去除B-domain的第八因子(BDD-rFVIII)來治療而產生抗體的一位血友病患者 Successful Immune Tolerance Induction Therapy Without Immune Anamnestic Response in a Previously-treated Hemophiliac with Full-length rFVIII and Inhibitors Developing After Switching Treatment to B-domain Deleted rFVIII. 2013,5,18.

30. 張家堯.台灣血栓暨止血學會101年度第二次學術研討會: 遺傳性血小板疾病2012年新知 Post-WFH review: Inherited Platelet Disorders. 2012,8,25.

31. 張家堯.台灣血栓暨止血學會101年度聯合年會: 新生兒與兒童的抗血栓治療指引 ACCP guideline: Antithrombotic Therapy in Neonates and Children. 2012,5,19.

32. 張家堯.台灣血栓暨止血學會101年度聯合年會: 台灣的血友病之診斷年齡、死亡率、與13年的趨勢:1997-2009健保資料庫的一個全國性研究 Age at diagnosis, mortality, and 13-year trend of hemophilia in Taiwan: a nationwide study by national health insurance research database 1997-2009. 2012,5,19.

33. 張家堯.臺灣兒科醫學會第208屆學術演講會: Hemophilia in Taiwan: a Nationwide Study on Demographics, Age at Diagnosis and Mortality 1998-2008. 2011,11,26.(No.81)

34. 張家堯.台灣血栓暨止血學會100年度第1屆學術研討會: 台灣的血友病-人口統計學與流行病學的全國性研究 Hemophilia in Taiwan: a Nationwide Study on Demographics and Epidemiology 1998-2008. 2011,10,1.(No.4)

35. 張家堯.台灣血栓暨止血學會100年度第1屆學術研討會: 類血友病與罕見出血性疾病2011年新知 Post-ISTH review: 1.Biology of Von Willebrand Factor and Phenotype/genotype Relationship in Von Willebrand Disease 2.Rare Bleeding Disorder: the Preliminary Analysis from EN-RBD Database. 2011,10,1.(Topic 3)

36. 張家堯.中華民國血液病學會、中華民國血液及骨髓移植學會第148次聯合學術研討會: Demographics and epidemiology of hemophilia in Taiwan: a nationwide study 1999-2008. 2011,9,3.(No.12)

37. 張家堯.中華民國血液病學會、中華民國血液及骨髓移植學會第147次聯合學術研討會: 成功以第七因子與正壓呼吸術來治療一位血友病抗體病患的血胸與顱內出血 Successful Treatment of Hemothorax and Intracranial Hemorrhage in a Hemophiliac with Inhibitors by Recombinant Factor VIIa and Positive Pressure Ventilation. 2011,4,16.(No.5)

38. 蔡佳叡、張家堯*.中華民國血液病學會、中華民國血液及骨髓移植學會第147次聯合學術研討會: 以難治性反覆小腿出血為表現的血友病患膕窩囊腫破裂 Popliteal Cyst Rupture in a Hemophiliac Presenting as Refractory Recurrent Right Lower Leg Hemorrhage. 2011,4,16.(No.4)

39. 張家堯. 中華民國血液病學會、中華民國血液及骨髓移植學會第145次聯合學術研討會: 成年血友病患者的骨質密度-台灣的前導型研究 Bone mineral density among adults with hemophiliacs: the pilot study in Taiwan.2010,8,14.

 

    更新日期:2021.03.20
                                                               更新者:張家堯